Innovita Research is a reputable research and development company that specializes in the fields of immunology and regenerative medicine. With a strong focus on aging prevention, immunotherapeutic cancer treatment, and regenerative medicine, Innovita Research is at the forefront of scientific advancements in these areas. The company prides itself on developing innovative cell-based technologies that aim to combat degenerative diseases using natural and recombinant proteins, as well as cells and their components.

Additionally, Innovita Research excels in cancer immunotherapy, leveraging xenogeneic differentiation antigens to provide effective treatment options. Moreover, Innovita Research offers leucocyte-based technologies that target antitumor, anti-infectious, and tissue-protective purposes. T-cell-based immunotherapy for autoimmune disorders is also included in their diverse range of offerings.

To support researchers in these fields, Innovita Research provides cutting-edge technologies and related products. The company further extends its services by offering high-quality pre-clinical trials for substances, devices, and technologies. With a commitment to scientific innovation and advancement, Innovita Research continues to shape the future of healthcare and contribute to the development of groundbreaking solutions